Analyst Ratings for Health Care REIT (HCN) [Neutrals]
HCN Rating Summary
HCN Price Target Summary
- Highest: $71.00 (Barclays)
- Lowest: $43.00 (Goldman Sachs)
- Average: $59.71
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$59.71 (-22.7%)
Avg. $ Target:
$59.71 (-22.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2013 | Macquarie | Downgrade | Neutral (Outperform) |
N/A (N/A) |
65.44 | 77.29 | 18.11% | Details |
| 1/16/2013 | JPMorgan | Downgrade | Neutral (Overweight) |
63.00 (63.00) |
61.81 | 77.29 | 25.04% | Details |
| 8/23/2012 | UBS | Downgrade | Neutral (Buy) |
N/A (N/A) |
58.14 | 77.29 | 32.94% | Details |
| 2/17/2012 | Sandler O’Neill | Downgrade | Hold (N/A) |
N/A (N/A) |
55.62 | 77.29 | 38.96% | Details |
| 1/18/2012 | BofA/Merrill Lynch | Downgrade | Neutral (N/A) |
N/A (N/A) |
55.70 | 77.29 | 38.76% | Details |
| 10/31/2011 | Stifel Nicolaus | Downgrade | Hold (N/A) |
N/A (N/A) |
53.54 | 77.29 | 44.36% | Details |
| 5/13/2011 | Jefferies » Updated 9/17/2012 |
Downgrade | Hold (N/A) |
57.00 (56.00) |
51.71 | 77.29 | 49.47% | Details |
